Premature centromere division (PCD): a dominantly inherited cytogenetic anomaly

1987 ◽  
Vol 77 (2) ◽  
pp. 193-196 ◽  
Author(s):  
K. Madan ◽  
D. Lindhout ◽  
A. Palan
CYTOLOGIA ◽  
1995 ◽  
Vol 60 (2) ◽  
pp. 159-165
Author(s):  
M. I. Arrieta ◽  
B. Martínez ◽  
M. Nuñez ◽  
A. Gil ◽  
A. Echarri ◽  
...  

2010 ◽  
Vol 62 (1) ◽  
pp. 63-74
Author(s):  
V. Bajic ◽  
Z. Stanimirovic ◽  
Jevrosima Stevanovic ◽  
Zorka Milicevic ◽  
Lada Zivkovic ◽  
...  

Premature centromere division (PCD) can be viewed as a manifestation of chromosome instability. In order to evaluate the ability of Paclitaxel (Ptx) and Cycloheximide (Cy) to induce PCD we used a cytokinesis block micronucleus assay (CBMN), fluorescent in situ hybridization (FISH), and the chromosome aberration (CA) assay in human peripheral blood lymphocytes. Results showed that Ptx can induce PCD alone or in combination with Cy. These findings call us to pay more attention to PCD as a parameter of genotoxicity in the pre-clinical research of mono and/or combinational therapies for cancer treatment.


2011 ◽  
Vol 63 (3) ◽  
pp. 603-608 ◽  
Author(s):  
B. Spremo-Potparevic ◽  
L. Zivkovic ◽  
B. Plecas-Solarovic ◽  
V.P. Bajic

Alzheimer?s disease (AD), as the most common form of dementia, has for many years attracted the attention of researchers around the world, primarily because of the problems of reliable diagnostic methods that could help in the early detection of this devastating disease. One of the important aspects of genetic research related to AD is the analysis of chromosome instability which includes: aneuploidies of different chromosomes, telomere shortening and the phenomenon of premature centromere division (PCD). The aim of this study was to describe specific biomarkers in different types of cells as potential parameters for the diagnosis of AD in order to promptly recognize pre-symptomatic stages and prevent the development of disease and/or slow down its progression.


2002 ◽  
Vol 112 (2) ◽  
pp. 215-216 ◽  
Author(s):  
K. Méhes ◽  
P. Kajtár ◽  
G. Kosztolányi

Anemia ◽  
2010 ◽  
Vol 2010 ◽  
pp. 1-7 ◽  
Author(s):  
Petra van der Lelij ◽  
Anneke B. Oostra ◽  
Martin A. Rooimans ◽  
Hans Joenje ◽  
Johan P. de Winter

Fanconi anemia (FA) is a recessively inherited disease characterized by multiple symptoms including growth retardation, skeletal abnormalities, and bone marrow failure. The FA diagnosis is complicated due to the fact that the clinical manifestations are both diverse and variable. A chromosomal breakage test using a DNA cross-linking agent, in which cells from an FA patient typically exhibit an extraordinarily sensitive response, has been considered the gold standard for the ultimate diagnosis of FA. In the majority of FA patients the test results are unambiguous, although in some cases the presence of hematopoietic mosaicism may complicate interpretation of the data. However, some diagnostic overlap with other syndromes has previously been noted in cases with Nijmegen breakage syndrome. Here we present results showing that misdiagnosis may also occur with patients suffering from two of the three currently known cohesinopathies, that is, Roberts syndrome (RBS) and Warsaw breakage syndrome (WABS). This complication may be avoided by scoring metaphase chromosomes—in addition to chromosomal breakage—for spontaneously occurring premature centromere division, which is characteristic for RBS and WABS, but not for FA.


Sign in / Sign up

Export Citation Format

Share Document